Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 5 | 2021 | 1194 | 0.310 |
Why?
|
| Fetal Blood | 2 | 2016 | 73 | 0.240 |
Why?
|
| Lymphadenopathy | 1 | 2021 | 23 | 0.180 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 51 | 0.170 |
Why?
|
| Exercise | 2 | 2017 | 938 | 0.160 |
Why?
|
| Vaccination | 1 | 2021 | 356 | 0.150 |
Why?
|
| Muscle Strength | 1 | 2017 | 39 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2017 | 188 | 0.130 |
Why?
|
| Fetal Stem Cells | 1 | 2014 | 3 | 0.120 |
Why?
|
| Quality of Life | 1 | 2021 | 1221 | 0.110 |
Why?
|
| Stem Cells | 1 | 2016 | 259 | 0.110 |
Why?
|
| Pre-Eclampsia | 1 | 2014 | 73 | 0.110 |
Why?
|
| Pregnancy | 2 | 2016 | 2326 | 0.090 |
Why?
|
| Neoplasms | 1 | 2021 | 1350 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 2 | 2009 | 55 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2009 | 46 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 283 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2006 | 24 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 434 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2016 | 670 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 521 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 667 | 0.050 |
Why?
|
| Survivorship | 1 | 2021 | 14 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 95 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 186 | 0.040 |
Why?
|
| Female | 6 | 2021 | 32566 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 964 | 0.040 |
Why?
|
| Adult | 4 | 2017 | 16672 | 0.030 |
Why?
|
| Humans | 7 | 2021 | 62865 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2017 | 100 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 1159 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2016 | 33 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 890 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 175 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 166 | 0.030 |
Why?
|
| Breast | 1 | 2016 | 183 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 208 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5408 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 545 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2014 | 1348 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2155 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2009 | 110 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 241 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 128 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1534 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 418 | 0.020 |
Why?
|
| Aged | 2 | 2017 | 14268 | 0.020 |
Why?
|
| Middle Aged | 2 | 2017 | 17391 | 0.020 |
Why?
|
| Fixatives | 1 | 2006 | 17 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2006 | 17 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2006 | 34 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 5596 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 503 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 169 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 1197 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 4655 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 6195 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2009 | 6545 | 0.010 |
Why?
|
| Male | 1 | 2014 | 29552 | 0.010 |
Why?
|